Compare MRNA & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRNA | FHN |
|---|---|---|
| Founded | 2010 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 11.0B |
| IPO Year | 2018 | N/A |
| Metric | MRNA | FHN |
|---|---|---|
| Price | $25.14 | $22.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 20 |
| Target Price | ★ $33.91 | $24.05 |
| AVG Volume (30 Days) | ★ 10.0M | 5.9M |
| Earning Date | 11-06-2025 | 01-15-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | N/A | ★ 20.88 |
| EPS | N/A | ★ 1.65 |
| Revenue | $2,232,000,000.00 | ★ $3,184,000,000.00 |
| Revenue This Year | N/A | $12.70 |
| Revenue Next Year | $0.77 | $2.54 |
| P/E Ratio | ★ N/A | $13.73 |
| Revenue Growth | N/A | ★ 3.68 |
| 52 Week Low | $22.28 | $15.19 |
| 52 Week High | $48.92 | $23.70 |
| Indicator | MRNA | FHN |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 62.17 |
| Support Level | $23.92 | $22.22 |
| Resistance Level | $26.00 | $21.93 |
| Average True Range (ATR) | 1.19 | 0.53 |
| MACD | 0.09 | 0.15 |
| Stochastic Oscillator | 72.59 | 98.50 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.